glycocyamine has been researched along with Cardiovascular Diseases in 7 studies
glycocyamine: RN given refers to parent cpd; structure
guanidinoacetate : A monocarboxylic acid anion that is the conjugate base of guanidinoacetic acid, obtained by deprotonation of the carboxy group.
guanidinoacetic acid : The N-amidino derivative of glycine.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (42.86) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 3 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hanff, E | 1 |
Said, MY | 1 |
Kayacelebi, AA | 1 |
Post, A | 1 |
Minovic, I | 1 |
van den Berg, E | 1 |
de Borst, MH | 1 |
van Goor, H | 1 |
Bakker, SJL | 1 |
Tsikas, D | 1 |
Ostojic, SM | 2 |
Trivic, T | 1 |
Drid, P | 1 |
Stajer, V | 1 |
Vranes, M | 2 |
Loncar, D | 1 |
Zenic, N | 1 |
Sekulic, D | 1 |
BORSOOK, H | 2 |
BORSOOK, ME | 2 |
GRAYBIEL, A | 1 |
PATTERSON, CA | 1 |
Andrade, F | 1 |
Rodríguez-Soriano, J | 1 |
Prieto, JA | 1 |
Elorz, J | 1 |
Aguirre, M | 1 |
Ariceta, G | 1 |
Martin, S | 1 |
Sanjurjo, P | 1 |
Aldámiz-Echevarría, L | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effects of Medium-term Oral Guanidinoacetic Acid (GAA) Administration on Human Performance, Body Composition, and Metabolic Outcomes in Physically Active Men and Women[NCT01133899] | Phase 1/Phase 2 | 40 participants (Actual) | Interventional | 2010-03-31 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for glycocyamine and Cardiovascular Diseases
Article | Year |
---|---|
Effects of Guanidinoacetic Acid Loading on Biomarkers of Cardiometabolic Risk and Inflammation.
Topics: Biomarkers; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Dietary Supplements; Fema | 2018 |
6 other studies available for glycocyamine and Cardiovascular Diseases
Article | Year |
---|---|
High plasma guanidinoacetate-to-homoarginine ratio is associated with high all-cause and cardiovascular mortality rate in adult renal transplant recipients.
Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Cross-Sectional Studies; Female; Follow-Up Stu | 2019 |
Guanidinoacetic Acid and Creatine are Associated with Cardiometabolic Risk Factors in Healthy Men and Women: A Cross-Sectional Study.
Topics: Adolescent; Adult; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Cholesterol; Chroma | 2018 |
The biochemical basis of betaine-glycocyamine therapy.
Topics: Betaine; Biochemical Phenomena; Cardiovascular Diseases; Creatine; Glycine; Humans | 1951 |
Treatment of cardiac decompensation with betaine and glycocyamine.
Topics: Betaine; Biochemical Phenomena; Cardiovascular Diseases; Creatine; Glycine; Heart Failure; Humans | 1951 |
Use of betaine and glycocyamine in the treatment of patients with heart disease: preliminary report.
Topics: Betaine; Cardiovascular Diseases; Creatine; Glycine; Heart Diseases; Humans | 1951 |
The arginine-creatine pathway is disturbed in children and adolescents with renal transplants.
Topics: Adolescent; Arginine; Cardiovascular Diseases; Case-Control Studies; Child; Creatine; Creatinine; Fe | 2008 |